Keros Therapeutics (KROS) Other financing activities (2020 - 2024)
Keros Therapeutics (KROS) reported Other financing activities of $130000.0 for Q3 2024, up 381.48% on a YoY basis from $27000.0 in Q4 2023, and up 94.03% quarter-over-quarter from $67000.0 in Q4 2023.
Keros Therapeutics (KROS) Other financing activities (2020 - 2024) Analysis & Trends
Keros Therapeutics has reported Other financing activities for 4 years, with the latest figure at $130000.0 in Q3 2024.
- For the quarter ending Q3 2024, Other financing activities rose 381.48% year-over-year to $130000.0; the trailing twelve-month figure through Dec 2025 stood at $130000.0 (down 41.96% YoY), and the FY2024 full-year result was $171000.0, up 81.91% from the prior year.
- Other financing activities for Q3 2024 stood at $130000.0, up from $67000.0 in the prior quarter.
- The five-year high for Other financing activities was $219000.0 in Q1 2020, with the low at $8000.0 in Q2 2020.
- Historically, Other financing activities has averaged $106285.7 across 4 years, with a median of $100000.0 in 2021.
- Annual changes were most pronounced in 2021 — Other financing activities plunged 48.19% — and 2024, when it jumped 381.48%.
- Keros Therapeutics' Other financing activities stood at $193000.0 in 2020, then sank by 48.19% to $100000.0 in 2021, then plunged by 33.0% to $67000.0 in 2023, then surged by 94.03% to $130000.0 in 2024.
- The last three Other financing activities figures came in at $130000.0 (Q3 2024), $67000.0 (Q4 2023), and $27000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Keros Therapeutics | 372.58 Mn | 85.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 130,000.00 |
| Sep 30, 2024 | 130,000.00 |
| Dec 31, 2023 | 67,000.00 |
| Dec 31, 2023 | 67,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Dec 31, 2020 | 193,000.00 |
| Dec 31, 2020 | 193,000.00 |
| Jun 30, 2020 | 8,000.00 |
| Jun 30, 2020 | 8,000.00 |
| Mar 31, 2020 | 219,000.00 |
| Mar 31, 2020 | 219,000.00 |